Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-02-24 @ 11:00 AM
Study NCT ID:
NCT03943056
Status:
COMPLETED
Last Update Posted:
2021-03-22
First Post:
2019-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-07
First Submit QC Date:
None
Study First Post Date:
2019-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-19
Last Update Post Date:
2021-03-22
Last Update Post Date Type:
ACTUAL